Skip to content
Open access

A quantitative disorder-phenotype atlas of inherited metabolic disorders reveals shared symptom spaces and group-specific hotspots.

Oct 2026 · Molecular Genetics and Metabolism · Vol 149 3, pp. 110289 · 0 citations · 33 references
Medicine

TL;DR

This first-generation knowledgebase-level atlas quantifies reported disorder-level phenotype architecture rather than patient-level prevalence or natural history rather than patient-level prevalence or natural history and provides a scalable framework for phenotype standardization, diagnostic navigation, targeted curation, and future integration of age, variants, treatment, and real-world evidence.

Abstract

Background

Inherited metabolic disorders (IMDs) are classified by pathway and gene, but their multisystemic presentation complicates phenotype-first diagnosis.

Methods

Using a frozen IEMbase export, we analyzed expert-curated disorder-level phenotype annotations for 1737 IMDs across 21 phenotype domains, 24 disorder groups, and 122 subgroups. We quantified annotation frequency, multi-domain burden, and group-domain enrichment using binomial z-scores, with clustering, principal component analysis, and bipartite networks for higher-order structure. Primary analyses were age-independent; age coverage was assessed exploratorily.

Results

Disorders involved a mean of 4.01 ± 2.54 phenotypic categories. Neurologic involvement was annotated in 70.5%, followed by Eye (38.3%) and Other (34.7%). Enrichment identified hotspots, including endocrine metabolic disorders → Endocrine (z ≈ 12.6) and congenital disorders of glycosylation → Dysmorphic/Skeletal (z ≈ 10.3/8.0), with glycosylation and mitochondrial phenotype clouds. Age-specific information was available for 98.7% of disorders in at least one interval, but only 28.9% spanned all five.

Conclusions

This first-generation knowledgebase-level atlas quantifies reported disorder-level phenotype architecture rather than patient-level prevalence or natural history. It provides a scalable framework for phenotype standardization, diagnostic navigation, targeted curation, and future integration of age, variants, treatment, and real-world evidence.

Read PDF

Similar papers

Open access Nov 2026

Unsupervised Phenotypic Stratification of 22q11.2 Deletion Syndrome for Improved Clinical Screening

Objective: 22q11.2 deletion syndrome (22q11DS) is the leading genetic cause of palatal anomalies, presenting a heterogeneous spectrum of clinical manifestations that complicates early diagnosis. No study has systematically investigated the co-occurrence of symptoms spanning cardiovascular, neuropsychiatric, craniofacia...

L. A. Azevedo Soares, D. Domeneghetti de Francisco, V. Gil-da-Silva-Lopes et al. · 0 citations
Review Open access Nov 2026

Molecular Diagnostic Biomarkers in Autism Spectrum Disorder: From Multi-Omics Signatures to Precision Therapeutic Targets

Autism spectrum disorder (ASD) is a systemic multi-organ condition characterized by profound biological heterogeneity. Clinical management currently faces a bottleneck due to reliance on subjective behavioral phenotyping rather than objective molecular markers. This review synthesizes breakthroughs in ASD diagnostics,...

Yang-Hao Zheng, Ming-Zhe Zhao · 0 citations
Open access Sep 2026

Multi-axis metabolic 3D modelling identifies a distinct phenotype in double negative demyelinating disease

This framework resolves overlapping and clinically ambiguous phenotypes, improves separation of progressive and seronegative cases, and reveals DN as a heterogeneous entity that is metabolically distinct from MS while demonstrating closer proximity to MOGAD.

Yi-Nuo Zang, Daniel C. Anthony, T. Yeo et al. · 0 citations
Open access Sep 2026

Integrating Single-Molecule Variant Phenotyping with Clinical Features Predicts Outcomes in KIF1A-Associated Neurological Disorder

Using KIF1A-associated neurological disorder (KAND) as a model system, single-molecule biophysical phenotyping of 91 pathogenic variants with longitudinal clinical characterization of 343 patients offers a prognostic tool and a stratification strategy for clinical trials.

Lu Rao, Wen-Xing Li, Jessica Waxler et al. · 0 citations
Open access Sep 2026

SysNDD: A Systematic Database for Neurodevelopmental Disorders

Neurodevelopmental disorders (NDDs) are clinically and genetically heterogeneous, and evidence linking additional genes to disease evolves rapidly. We developed SysNDD, an open-access, expert-curated resource that represents distinct gene-inheritance-disease associations as entities with standardized confidence, phenot...

B. Popp, Simon P. Früh, M. Altay et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.